Beyond Air, Inc. — Director's Dealing 2019

Feb 25, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AIT Therapeutics, Inc. (AITB)
CIK: 0001641631
Period of Report: 2018-12-31

Reporting Person: Lisi Steven A. (Director, CEO, Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-12-31	Common Stock	A	88000	—	Acquired	452286	Direct
2019-01-01	Common Stock	A	12000	—	Acquired	464286	Direct

Footnotes

F1: Represents restricted stock award that vest in five equal annual installments commencing on the date of grant.